TNF-α-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate

Journal of Cellular Physiology

Volumn 206, Issue 3, 2006, Pages 709-717

  Vindrieux, David ^a   Réveiller, Marie ^a   Florin, Anne ^a   Blanchard, Cécile ^a   Ruffion, Alain ^a,b   Devonec, Marian ^a,b   Benahmed, Mohamed ^a   Grataroli, Renée ^a  

^a INSERM   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIANDROGEN; DEATH RECEPTOR; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FLUTAMIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND DECOY RECEPTOR 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CASTRATION; CELL DEATH; CONTROLLED STUDY; HORMONE ACTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE VENTRAL LOBE; PROTEIN FUNCTION; RAT; RAT STRAIN; RECEPTOR INTRINSIC ACTIVITY;

ANDROGEN ANTAGONISTS; ANDROGENS; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASTRATION; FLUTAMIDE; HELA CELLS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TESTOSTERONE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 31944436030     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20520     Document Type: Article

References (48)

1. Almasan A, Ashkenazi A. 2003. Apo2L/TRAIL: Apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14:337-348.
2. Asamoto M, Hokaiwado N, Cho YM, Takahashi S, Ikeda Y, Imaida K, Shirai T. 2001. Prostate carcinoma developing in transgenic rats with SV40 antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res 61:4693-4700.
3. Ashkenazi A. 2002. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev/Cancer 2:420-430.
4. Ashkenazi A, Dixit VM. 1999. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11:255-260.
5. Avila DM, Fuqua SA, George FW, McPhaul MJ. 1998. Identification of genes expressed in the rat prostate that are modulated differently by castration and finasteride traitment. J Endocrinol 159:403-411.
6. Banerjee PP, Banerjee S, Tilly KI, Tilly JL, Brown TR, Zirkin BR. 1995. Lobe-specific apoptotic cell death in rat prostate after androgen ablation by castration. Endocrinology 136:4368-4376.
7. Banerjee PP, Banerjee S, Brown TR. 2002. Bcl-2 protein expression correlates with cell survival and androgen independence in rat prostatic lobes. Endocrinology 143:1825-1832.
8. De la Taille A, Chen MW, Shabeigh A, Bagiella E, Kiss A, Buttyan R. 1999. Fas antigen/CD-95 upregulation and activation during castration-induced regression of the rat ventral prostate gland. Prostate 40:89-96.
9. Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG, Smith CA. 1997. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 186:1165-1170.
10. Degterev A, Boyce M, Yuan J. 2003. A decade of caspases. Oncogene 22:8543-8567.
11. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, Dodds RA, James IE, Rosenberg M, Lee JC, Young PR. 1998. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273:14363-14367.
12. Gleave ME, Zellweger T, Chi K, Miyake H, Kiyama S, July L, Leung S. 2002. Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisens oligonucleotides to enhance androgen- and chem-sensitivity in prostate cancer. Invest New Drugs 20:145-158.
13. Grataroli R, Vindrieux D, Gougeon A, Benahmed M. 2002. Expression of tumor necrosis factor-alpha-related apoptosis-inducing ligand and its receptors in rat testis during development. Biol Reprod 66:1707-1715.
14. Grataroli R, Vindrieux D, Selva J, Felsenheld C, Ruffion A, Decaussin M, Benahmed M. 2004. Characterization of tumour necrosis factor-α-related apoptosis-inducing ligand and its receptors in the adult human testis. Mol Hum Reprod 10:123-128
15. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. 2000. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12:611-620.
16. Kwong J, Choi HL, Huang Y, Chan FL. 1999. Ultrastructural and biochemical observations on the early changes in apoptotic epithelial cells of the rat prostate induced by castration. Cell Tissue Res 298:123-136.
17. Kyprianou N, Isaacs JT. 1988. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562.
18. Lekas E, Johansson M, Widmark A, Bergh A, Damber JE. 1997. Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration. Urol Res 25:309-314.
19. Lin SL, Chuong CM, Ying SY. 2001. A novel mRNA-CDNA interference phenomenon for silencing bcl-2 expression in human LNCaP cells. Biochem Biophys Res Commun 281:639-644.
20. Liu QY, Rubin MA, Omene C, Lederman S, Stein CA. 1998. Fas ligand is constitutively secreted by prostate cancer cells in vitro. Clin Cancer Res 4:1803-1811.
21. Mac Farlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES. 1997. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem 272:25417-25420.
22. Masters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A, Goddard AD, Godowski P, Ashkenazi A. 1997. A novel receptor for Apo2L/TRAIL countains a truncated death domain. Curr Biol 7:1003-1006.
23. Nagata S. 1997. Apoptosis by death factor. Cell 88:355-365.
24. Nastiuk KL, Kim JW, Mann M, Krolewski JJ. 2003. Androgen regulation of FLICE-like inhibitory protein gene expression in the rat prostate. J Cell Physiol 196:386-393.
25. Omezzine A, Chater S, Mauduit C, Florin A, Tabone E, Chuzel F, Bars R, Benahmed M. 2003a. Long-term apoptotic cell death process with increased expression and activation of caspase-3 and -6 in adult rat germ cells exposed in utero to flutamide. Endocrinology 144:648-661.
26. Omezzine A, Mauduit C, Tabone E, Nabli N, Bouslama A, Benahmed M. 2003b. Caspase-3 and -6 expression and activation are targeted by hormone action in the rat ventral prostate during the apoptotic cell death process. Biol Reprod 69:752-760.
27. Pan G, Ni J, Wei YF, Yu GL, Gentz R, Dixit VM. 1997a. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815-818.
28. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM. 1997b. The receptor for the cytotoxic ligand TRAIL. Science 276:111-113.
29. Pan G, Ni J, Yu GL, Wei YF, Dixit VM. 1998. TRUNDD: A new member of the TRAIL receptor family that antagonizes TRAIL signaling. FEBS Lett 424:41-45.
30. Peets EA, Henson MF, Neri R. 1974. On the mechanism of the anti-androgenic action of flutamide (α-α-α-trifluoro-2-methyl- 4′-nitro-m-propionotoluidide) in the rat. Endocrinology 94:532-540.
31. Perlman H, Zhang X, Chen MW, Walsh K, Buttyan R. 1999. An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelialcell apoptosis. Cell Death Differ 6:48-54.
32. Pitti RM, Masters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. 1996. Induction of apoptosis by Apo-2ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687-12690.
33. Reed JC. 1998. Bcl-2 family proteins. Oncogene 17:3225-3323.
34. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA, Cohen MB. 1997. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 57:1758-1768.
35. Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Syrbu SI, Cohen MB. 2002. TRAIL-DISC formation is androgen-dependent in the human prostatic carcinoma cell line LNCaP. Cancer Biol Ther 1:631-637.
36. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J. 1997. TRAIL receptors l (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7:831-836.
37. Shabsigh A, Tanji N, D'Agati V, Burchardt M, Rubin M, Goluboff ET, Heitjan D, Kiss A, Buttyan R. 1999. Early effects of castration on the vascular system of the rat ventral prostate gland. Endocrinology 140:1920-1926.
38. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WL, Goddard AD, Godowski P, Ashkenazi A. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818-821.
39. Shivapurkar N, Toyooka S, Toyooka KO, Reddy J, Miyajima K, Suzuki M, Shigematsu H, Takahashi T, Parikh G, Pass HI, Chaudhary PM, Gazdar AF. 2004. Aberrant methylation of TRAIL decoy receptor genes is frequent in multiple tumor types. Int J Cancer 109:786-792.
40. Smith CA, Farrah T, Goodwin RG. 1994. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959-962.
41. Suzuki A, Matsuzawa A, Iguchi T. 1996. Down regulation of bcl-2 is the first step in fas-mediated apoptosis of male reproductive tract. Oncogene 13:31-37.
42. Thornberry NA, Lazebnik Y. 1998. Caspases: Enemies within. Science 281:1312-1316.
43. van Noesel MM, van Bezouw S, Salomons GS, Voûte PA, Pieters R, Baylin SB, Herman JG, Versteeg R. 2002. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation. Cancer Res 62:2157-2161.
44. Vindrieux D, Devonec M, Benahmed M, Grataroli R. 2002. Identification of tumor necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL) and its receptors in adult rat ventral prostate. Mol Cell Endocrinol 198:115-121.
45. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH. 1999. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157-163.
46. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682.
47. Woolveridge I, Taylor MF, Wu FC, Morris ID. 1998. Apoptosis and related genes in the rat ventral prostate following androgen ablation in response to ethane dimethanesulfonate. Prostate 36:23-30.
48. Wright AS, Thomas LN, Douglas RC, Lazier CB, Rittmaster RS. 1996. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat. J Clin Invest 98:2558-2563.